Different Doses of Colchicine on hsCRP
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT06078904
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Registry
-
NCT06078904
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06078904. Randomized; quadruple masking; primary purpose treatment. Start 2023-10-10 (actual); primary completion 2023-12-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Different Doses of Colchicine on hsCRP
- Condition
- Coronary Artery Disease
- Condition
- Percutaneous Coronary Intervention
- Intervention (Drug)
- Colchicine 0.5 MG
- Intervention (Drug)
- Colchicine 0.375 MG
- Intervention (Drug)
- Colchicine 0.25 MG
- Intervention (Drug)
- Placebo
- Lead sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Record details
- Record id
cardio:ct-nct06078904- Content hash
0ad1822f56fa7cb001af96e250e8df0592bca68088d63c60bac1b16ce0c748e9